I. To determine the role of expression patterns and/or activation of insulin-like growth factor (IGF)- and epidermal growth factor receptor (ErbB) family of receptors and signaling molecules in formalin-fixed, paraffin-embedded breast tumor tissue in predicting response to lapatinib and capecitabine +/- IMC-A12.